By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia And Eli Lilly (LLY) Initiate Phase 1b Study Evaluating Ultra-Rapid Insulin BioChaperone Lispro U100 In Healthy Japanese Subjects 1/29/2016 8:59:12 AM
Adocia To Hold Conference Call For Investors To Provide 2015 Annual Business Update And Perspectives For 2016 Thursday December 17, 2015 at 5:45 PM (CET) 12/16/2015 11:03:40 AM
Adocia And Eli Lilly (LLY) Report Positive Results Of A Pilot Bioequivalence Study Comparing Biochaperone Lispro U200 To Biochaperone Lispro U100 12/11/2015 9:38:04 AM
Adocia Announces Positive Phase 1b Results Of BioChaperone Combo In Patients With Type 2 Diabetes 11/25/2015 1:09:12 PM
Adocia Announces Positive Phase 1b Results On The Post-Meal Effect Of BioChaperone Combo In Patients With Type 1 Diabetes 11/4/2015 2:03:07 PM
Adocia Reports Third Quarter 2015 Financial Results 10/13/2015 2:57:14 PM
Adocia And Eli Lilly (LLY) Initiate A Phase 1b Study Evaluating Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes Using Insulin Pump Therapy 10/6/2015 9:32:02 AM
Adocia And Eli Lilly (LLY) Initiate New Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro In Patients With Type 1 Diabetes 8/27/2015 9:53:50 AM
Adocia Presents Financial Results For The First Half Of 2015 Highlighting Strong Growth 7/21/2015 2:07:27 PM
Adocia Initiates Two Clinical Studies On Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro, Biochaperone Combo 7/10/2015 1:58:14 PM
12345
//-->